BioRestorative Therapies to Showcase Advances in Regenerative Medicine
BioRestorative Therapies to Showcase Advances in Regenerative Medicine
BioRestorative Therapies, Inc. (NASDAQ: BRTX), a leader in regenerative medicine focused on stem cell therapies, has announced its participation in important upcoming investor events. The company is dedicated to pioneering advancements in regenerative medicine and has made significant strides in developing innovative therapies.
Upcoming Investor Engagements
The company is set to take part in two significant investor events this month:
UBS Virtual Organ Restoration and Cell Therapy Day
Lance Alstodt, the CEO of BioRestorative, will engage in a fireside chat with UBS's analyst, Ash Verma, who specializes in biotech and specialty pharma. This session will take place at 1:00 p.m. ET on October 15, 2024. This event will provide investors with insights into BioRestorative's operations and future prospects in cell therapy.
Maxim Healthcare Virtual Summit
Another engagement on the calendar is the 2024 Maxim Healthcare Virtual Summit. Mr. Alstodt will again be featured in a discussion with Jason McCarthy, Ph.D., who heads biotechnology research at Maxim Group. This chat, scheduled for October 17, 2024, at 11:00 a.m. ET, promises to delve deeper into the company’s innovative approaches and therapeutic developments.
About BioRestorative Therapies, Inc.
BioRestorative Therapies aims to develop cutting-edge therapeutic products based on advanced cell and tissue protocols, predominantly leveraging adult stem cells. The company has two primary clinical programs that address significant health concerns, particularly in the realm of regenerative therapies.
Disc/Spine Program: brtxDISC™
The flagship therapy, BRTX-100, utilizes a patient’s own cultured mesenchymal stem cells harvested from their bone marrow. This treatment is designed for non-surgical interventions to relieve pain caused by lumbosacral disc disorders. By employing proprietary technology, BioRestorative collects, cultures, and cryopreserves the stem cells, which are then injected into the affected discs by a health professional. The company is currently in its Phase 2 clinical trial, demonstrating its commitment to innovative solutions for chronic lower back pain management.
Metabolic Program: ThermoStem®
In addition to spinal therapies, BioRestorative is developing therapies to manage obesity and metabolic disorders. This program harnesses brown adipose derived stem cells (BADSC) to create brown adipose tissue (BAT), which plays a crucial role in energy metabolism. Preclinical studies suggest that individuals with higher brown fat levels may experience less obesity and improved metabolic functions, making this line of research particularly promising for future therapeutic options.
BioCosmeceuticals: A New Frontier
Complementing its clinical programs, BioRestorative also operates in the aesthetic domain with its BioCosmeceutical platform. The company has developed a proprietary serum that combines exosomes, proteins, and growth factors aimed at enhancing skin appearance and mitigating aging signs. This product is manufactured in a clean room environment compliant with cGMP standards, emphasizing safety and efficacy in its formulations. Future endeavors include expanding the product line to cover a wider range of cell-based aesthetic therapies, potentially leading to FDA approvals as the company strives to innovate within the burgeoning BioCosmeceutical market.
Frequently Asked Questions
What is BioRestorative Therapies' primary focus?
BioRestorative Therapies focuses on developing regenerative medicine therapies, particularly those involving stem cell-based treatments.
What events will the company participate in?
BioRestorative Therapies will take part in the UBS Virtual Organ Restoration and Cell Therapy Day and the Maxim Healthcare Virtual Summit.
What is BRTX-100?
BRTX-100 is BioRestorative’s lead cell therapy candidate aimed at treating disc disorders non-surgically by utilizing the patient’s own stem cells.
How does the ThermoStem® program work?
ThermoStem® utilizes brown adipose derived stem cells to target obesity and metabolic issues by increasing brown adipose tissue, aiding in energy metabolism.
What are BioCosmeceuticals?
BioCosmeceuticals are products developed by BioRestorative that use cellular technology to enhance cosmetic outcomes, including reducing the visibility of fine lines.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Antonio Pineiro's Strategic Stock Option Purchase at Dave & Buster's
- Insider Trading Insights: George J Christ's Recent Sale of Shares
- Understanding Insider Activity at Altair Engineering - ALTR
- Smart Investing: The Critical Role of Homeownership
- Vertex's Stock Movements and Future Outlook Explained
- Vertex Insider Trade Sparks Investor Interest in Stock Moves
- Significant Insider Sale: Powell Industries' Thomas W Powell Moves Shares
- Keysight Launches Innovative 800GE Testing System for AI
- Integral Ad Science CFO Shares Insights From Recent Stock Moves
- Gigi Pip and Two Roads Hat Co. Set to Debut in Nashville
Recent Articles
- Key Insights from Preqin's Service Providers in Alternatives Report
- Surge in Medical Tricorder Demand Drives Market Toward Growth
- Exploring the Surge in Electric Vehicle Sound Generators
- Avacta Group Ltd. Showcases Innovative Cancer Therapies
- Aclarion CEO to Present at Upcoming Healthcare Summit
- ConnectOne Bancorp's Upcoming Conference Call on Q3 Results
- New Non-Executive Directors Join Alliance Witan PLC Board
- Reliance, Inc. Set to Reveal Q3 2024 Financial Insights Soon
- Innovative Solar Solutions for Sustainable Transportation
- Pfizer's TALZENNA and XTANDI Boost Survival in Cancer Patients
- AVPro Global Elevates MXnet Systems Group for Future Growth
- Lindsay Corporation Shares Q4 Earnings Call Plans Ahead
- Kontoor Brands Shares Exciting Third Quarter Earnings Update
- Lazard's AUM Surges to $247.7 Billion by September 2024
- Market Overview: Inflation Data Impacts Stock Futures Amid Key Events
- Delta Air Lines Reports Third Quarter Earnings Shortfall
- Bank of America Highlights Positives Amid Alphabet's Challenges
- Busbar Market Expected to Climb to $19.70 Billion by 2029
- Deutsche Telekom to Boost Earnings with New Buyback Strategy
- XING Mobility Unveils Innovative IMMERSIO™ CTC Battery Technology
- Weak Demand for iPhone 16 Raises Concerns for Apple Inc.
- Labcorp Offers Quarterly Cash Dividend to Shareholders
- BTIG Boosts Shift4 Payments Target Amid Strong Growth Prospects
- Mallinckrodt Expands INOmax EVOLVE DS System Availability
- Empire Petroleum Updates Shareholders on Rights Offering Progress
- Babcock & Wilcox Sells Subsidiaries to AUCTUS for $40 Million
- Sunrun's Stock Target Adjustment: A Promising Outlook Ahead
- JPMorgan Downgrades Boliden AB Amid Zinc Surplus Concerns
- How Bybit is Enhancing Blockchain Ecosystems Through Solana
- Wall Street's Bright Outlook As Fed Minutes Provide Clarity
- Conagra's Recent Earnings Miss: A Strategic Buying Opportunity
- Market Outlook: Anticipations for Inflation and Earnings Reports
- Exploring the Future Potential of Palantir Technologies
- Projected Growth of Fishmeal & Fish Oil Market to USD 13.8B
- Evaluating Google's Legal Challenges: Market Reactions Explained
- Global Frozen Potato Market Projected to Reach $98 Billion
- Exploring Affordable Investment Opportunities in Healthcare
- Exploring the Growth of the AI Camera Market Beyond 2023
- Mineral Fillers Industry Forecast: Growth and Innovations Ahead
- Economic Factors Shape Consumer Choices for Sustainable Deliveries
- Azimut Exploration Identifies Promising Lithium Zones in Quebec
- Orezone Gold Corp's Promising Drill Results Enhance Growth Prospects
- Immatics Shares New Phase 1b Data for Melanoma Therapy IMA203
- Zymeworks Announces Q3 2024 Financial Results and Call
- Man Group PLC’s Informative Position Disclosure Overview
- Domino's Pizza Faces Challenges Amidst Competitive Dining Market
- Nifty 50 Sees Slight Gains as Stock Market Remains Strong
- Delta Air Lines Expects Strong Q4 Earnings Amidst Challenges
- Delta Air Lines' Mixed Earnings Outlook Raises Concerns
- Delta Air Lines Surpasses Earnings Estimates in Strong Quarter